Search Results 1561-1570 of 20375 for pancreatic disease

  1. Brain metastases - Doctors and departments - Mayo Clinic

    Search for a disease or condition . Type 3 or more ... Pancreatic cancer, Esophageal cancer, Stomach ... disease, Oligodendroglioma, Central nervous ...

  2. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. ... Pancreatic cancer. Histologically or ...

  3. Rectal Cancer Clinical Trials - Mayo Clinic Research

    ... pancreatic cancers. A Study of Blood and Stool ... disease recurrence. ... disease is stable on, or responding to 1st line therapy for metastatic disease.

  4. Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease - Mayo Clinic

    Solid organ transplantation (e.g., kidney, pancreas, liver, lung, heart). Active immunosuppression therapy. History of active substance abuse (including ...

  5. Abiraterone (oral route) - Mayo Clinic

    The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:.

  6. Infectious Diseases A–Z: Why you should never take leftover antibiotics

    Related Articles. Research. Discovery reveals how to prevent organ damage in pancreatitis. Neurosciences. Mayo Clinic Minute: Reducing risk of Alzheimer's ...

  7. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. ... pancreatic enzymes are not eligible; ...

  8. Research Centers and Programs - Mayo Clinic Research

    Cardiovascular Disease and Outcomes Research Program ... and Billie Kelley Pirnie Translational Polycystic Kidney Disease ... Pancreatic Cancer Early Detection ...

  9. Publications - Jeremy Jones, M.D. - Mayo Clinic

    Circulating tumor DNA (ctDNA) to evaluate minimal residual disease (MRD), treatment response, and posttreatment prognosis in pancreatic adenocarcinoma.

  10. Publications - Steven R. Alberts, M.D., M.P.H. - Mayo Clinic

    ... Pancreatic Adenocarcinoma. Oncologist. 2022 Jul 5 ... Reevaluating Disease-Free Survival as an Endpoint ... disease recurrence following adjuvant ...